Financial writer predicts Medtronic's stock will rise due to recent product launches and improved margins, reaffirming a Buy rating for 2025.

Qualcomm is diversifying beyond mobile handsets into automotive, IoT, and PCs, driven by edge-AI applications, boosting ...

ARM's stock is overvalued, with a 25% growth expectation over 35 years, which is unrealistic given its erratic margins and headwinds. Arm Holdings' business model relies on licensing and royalties ...

UPS is poised for revenue growth due to U.S. industrial market recovery, SMB and healthcare focus, and improved service offerings.

XLY offers investors targeted exposure to cyclical consumer goods/services U.S companies. Consumer confidence remains stable, ...

A risk-free interest rate, also known as a risk-free rate of return, is a theoretical interest rate of an investment that carries no risk. Real risk-free rates are calculated by subtracting the rate ...

The Fund’s curve positioning and steepening bias were both positive contributors during the quarter while duration was a more ...

Jackson Financial stock is on a medium-term upward trend, outperforming the S&P 600 with impressive growth and profit ...

We have downgraded JPC CEF to Sell due to unsustainable 10.1% distribution rate and inadequate compensation for negatives.

The downside of aggressive Fed easing during the pandemic appears poised to take stocks down sharply. Read why I project S&P ...

I warn of Palantir's high valuation and risks despite strong growth, advising caution on adding shares. Read an investment ...

Bitcoin is increasingly being used in investment portfolios due to its efficiency and low transaction costs. Explore more ...